Do Han Kim et al.; "Kinetic Studies of Ca.sup.2+ Release from Sarcoplasmiceticulum of Normal and Malignant Hyperthermia Susceptible Pig Muscles" Biochimia et Biophysica Acta 775 (1984) 320-327. |
Ohnishi et al.; "Calcium-induced Ca.sup.2+ release from sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia"; FEBS Letters 161, No. 1; Sep. 1983; pp. 103-107. |
Ohta, et al.; "Ca-induced Ca release in malignant hyperthermia-suspectible pig skeletal muscle"; The American Physiologial Society 256 C358-C367 (1989). |
Endo et al.; "Changes in the Ca-Induced Ca Release Mechanism in the Sarcoplasmic Reticulum of the Muscle from a Patient with Malignant Hyperthermia" Biomedical Research 4 (1) 83-92 (1983). |
Otsu et al; "Molecular Cloning of cDNA Encloding the Ca.sup.2+ Release Channel (Ryanodine Receptor) of Rabbit Cardiac Muscle Sarcoplasmic Reticulum"; J Biol Chem 265:13472-13483. |
Harbitz et al; "Assignment of the Porcine Calcium Release Channel Gene, a Candidate for the Malignant Hyperthermia Locus, to 6p11.fwdarw.q21 Sequent of Chromosome 6"; Genomics 8:243-248 (1990). |
Fujui et al; "Identification of a Mutation in Porcine Ryanodine Receptor Associated with Malignant Hyperthermia"; Science 253:448-451 (1991). |
Knudson et al., "Distinct Immunopeptide Maps of the Sarcoplasmic Reticulum Ca.sup.2+ Release Channel in Malignant Hyperthermia"; The Journal of Biological Chemistry 265:2421-2424 (1990). |
O'Brien, "Etiopathogenetic Defect of Malignant Hyperthermia: Hypersensitive Calcium-Release Channel of Skeletal Muscle Sarcoplasmic Reticulum"; Veterinary Research Communications 11 527-559 (1987). |
O'Brien et al., "Malignant Hyperthermia Susceptibility: Biochemical Basis for Pathogenesis and Diagnosis"; Can J Vet Res 54: 83-92 (1990). |
P.J. O'Brien, "Porcine Malignant Hyperthermia Susceptibility: Hypersensitive Calcium-release Mechanism of Skeletal Muscle Sarcoplasmic Reticulum"; Can J Vet Res 50: 318-328 (1986). |
P.J. O'Brien, "Porcine Malignant Hyperthermia Susceptibility: Increased Calcium-sequestering Activity of Skeletal Muscle Sarcoplasmic Reticulum"; Can J Vet Res 50: 329-337 (1986). |
P.J. P'Brien, "Microassay for malignant hyperthermia susceptibility: hypersensitive ligand-gating of the Ca channel in muscle sarcoplasmic reticulum causes increased amounts and rates of Ca-release"; Molecular and Cellular Biochemistry 93:53-59 (1990). |
Marks et al., "Surface Topography Analysis of the Ryanodine Receptor/Junctional Channel Complex Based on Proteolysis Sensitivity Mapping"; J Biol Chem 265: 13143-13149 (1990). |
Davies et al., "Porcine malignant hyperthermia carrier detection and chromosomal assignment using a linked probe"; Animal Genetics 19: 203-212 (1988). |
O'Brien et al., "Porcine malignant hyperthermia susceptbility: Erythrocytic osmotic fragility"; Am J Vet Res 46 1451-1456 (1985). |
O'Brien, et al., "Malignant Hyperthermia Susceptibility: Cardiac Histomorphometry of Dogs and Young and Market-weight Swine"; Can J Vet Res 51: 505-55 (1987). |
O'Brien, et al., "Compensatory increase in calcium extrusion activity of untreated lymphocytes from swine susceptible to malignant hyperthermia"; Am J Vet Res 51: 1038-1043 (1990). |
Brenig et al., "The porcine PHIcDNA linked to the halothane gene detects a Hindlll and Xbal RFLP in normal and malignant hyperthermia susceptible pigs"; Nuc Acids Res 18: 388 (1990). |
Harbitz et al., "Assignment of the Porcine Calcium Release Channel Gene, a Candidate for the Malignant Hyperthermia Locus, to the 6p11--q21 Segment of Chromosome 6"; Genomics 8: 001-006 (1990). |
Nelson et al., "Evidence for Intraluminal Ca.sup.++ Regulatory Site Defect in Sarcoplasmic Reticulum from Malignant Hyperthermia Pig Muscle"; Journal of Pharmacology and Experimental Therapeutics 256: 645-649 (1991). |
Fill et al., "Abnormal ryanodine receptor channels in malignant hyperthermia"; Biophys J. Biophysical Society 57: 471-475 (1990). |
Ervasti et al., Ryanodine receptor in different malignant hyperthermia-susceptible porcine muscles; Am J Physiol 260 (Cell Physiol 29): C58-C66 (1991). |
Mickelson et al., "Abnormal Sarcoplasmic Reticulum Ryanodine Receptor in Malignant Hyperthermia"; J Biol Chem 263: 9310-9315 (1988). |
Zorzato et al., "Molecular Cloning of cDNA Encoding Human and Rabbit Forms of the Ca.sup.2+ Release Channel (Ryanodine Receptor) of Skeletal Muscle Sarcoplasmic Reticulum"; J Biol Chem 265: 2244-2256 (1990). |
Takeshima et al., "Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor"; Nature 339: 430-445 (1989). |
MacLennan; "The genetic basis of malignant hyperthermia"; TIPS 13: 330-334 (1992). |
MacLennan et al., "Malignant Hyperthermia"; Science 256: 789-794 (1992). |
MacLennan et al., "The Role of the Skeletal Muscle Ryanodine Receptor Gene in Malignant Hyperthermia"; Society for Experimental Biology 189-201 (1992). |
MacKenzie et al., "The Human Ryanodine Receptor Gene; Its Mapping to 19ql13.1, Placement in a Chromosome 19 Linkage Group, and Exclusion as the Gene Causing Myotonic Dystrophy"; Am J Hum Genet 46: 1082-1089 (1990). |
Gillard et al.; "A Substitution of Cysteine for Arginine 614 in the Ryanodine Receptor is Potentially Causative of Human Malignant Hyperthermia"; Genomics 11: 751-755 (1991). |
Gillard et al.; "Polymorphisms and Deduced Amino Acid Substitutions in the Coding Sequence of the Ryanodine Receptor (RYR1) Gene in Individuals with Malignant Hyperthermia"; Genomics 13: 1247-1254 (1992). |
MacLennan et al.; "Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia" Nature vol. 343, No. 6258 pp. 559-561; Feb. 8, 1990. |
Nelson; "Abnormality in Calcium Release from Skeletal Sarcoplasmic Reticulum of Pigs Susceptible to Malignant Hyperthermia"; The American Society for Clinical Investigation, Inc.; vol. 72, Sep. 1983. |
Mickelson, et al.; "Enhanced Ca.sup.2+ -induced calcium release by isolated sarcoplasmic reticulum vesicles from malignant hyperthermia susceptible pig muscle"; Biochimica et Biophysica Acta; 862 (1986); pp. 318-328. |
Gahne et al.; "Prediction of the halothane (Hal) genotypes of pigs by deducing Hal. Phi, Po2, Pdg haplotypes of parents and offspring: results from a large-scale practice in Swedish breeds"; Animal Blood Groups and Biochemical Genetics 16 (1985) pp. 265-283. |
Chowdhary et al.; "Localization of the glucose phosphate isomerase gene to the p12-q21 segment of chromosome 6 in pig by in situ hybridization" Hereditas 111; 73-78 (1989). |
Archibald et al.; "The halothane sensitivity locus and its linkage relationships" Animal Blood Groups and Biochemical Genetics 16 (1985) pp. 253-263. |
Andresen, et al.; "Close linkage established between the HAL locus for halothane sensitivity and the PHI (phosphohexoes isomerase) locus in pigs of the Danish Landrace breed" Nord. Vet. Med. 1977, 29, 302-304. |
Weir et al, Handbook of Experimental Immunology, 4th ed., (1986) pp. 26.1-26.56. |